Abstract
Impaired glucose metabolism and persistent hyperglycemia are known to cause diabetes complications. Diabetic hyperglycemia has been correlated with complications such as retinopathy, nephropathy, neuropathy, and increased the risk of myocardial infarction, stroke, premature peripheral arterial disease, atherosclerosis, and cardiomyopathy. Insulin resistance is the root cause of hyperglycemia, and insulin resistance is caused by obesity and tied to causative inflammatory factors. Many new pathways that impact this inflammation have been observed in the last decade. It is clear that obesity increases the likelihood of inflammation, alters the response of the adipose, and increases the risk of lipidemia and hyperglycemia. Hyperglycemia leads to oxidative stress which causes molecular damage. Adipose tissue under fatty acid stress is now implicated as a source of innate immunity signaling of inflammation. These stress factors caused by obesity correlate with a mild but chronic inflammatory state with activation of the innate immune system. This inflammatory state signals innate immune cells to mediate tissue and organ damage. Vascular dysfunction and altered cellular proliferation repair responses are observed. The pathways in innate immunity activation are herein reviewed and connections are made to both well-known diagnostic markers and to new markers. Immune mediated inflammation is common to all diabetic complications. Recent discoveries shown in the volume reveal a new level of complexity in the innate immune molecular role in diabetic disease. These multiple pathways allow a new understanding how diabetes complications progress. This chapter reviews the molecular pathways connecting hyperglycemia to obesity and inflammation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahima RS (2006) Adipose tissue as an endocrine organ. Obesity 14:242–249
Allen-Mersh TG (1976) Weber-Christian panniculitis and auto-immune disease: a case report. J Clin Pathol 29(2):144–149
Antonetti DA et al. JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabets. 2006;55(9):2401–2411
Aroor AA et al (2013) The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness (review). Front Endocrinol (Lausanne) 4:article 161, 7 pgs
Ban CR, Twigg SM (2008) Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 4(3):575–596. Review
Bashan N et al (2009) Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 89:27–71
Besler C (2011) Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 121(7):2693–2708
Bierhaus A et al (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 83(11):876–886
Brady EM et al (2012) Investigating endothelial activation and oxidative stress in relation to glycaemic control in a multiethnic population. Exp Diabetes Res 2012:386041
Bråkenhielm E et al (2004) Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A 101(8):2476–2481
Brooks-Worrell B, Palmer JP (2011) Is diabetes mellitus a continuous spectrum? Clin Chem 57(2):2158–2161
Calkin AC, Tontonoz P (2013) Transcriptional integration of metabolism by the nuclear sterol activated receptors LXR and FXR. Nat Rev Mol Cell Biol 13(4):213–224
Calvo C, Ponsin G, Berthezene F (1988) Characterization of the non-enzymatic glycation of high density lipoprotein in diabetic patients. Diabete Metab 14(3):264–269
Campbell DJ (2000) Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides. Br J Med Biol Res 33:665–677
Campbell DJ (2001) The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol 28:1060–1065
Ceriello A, Ihnat MA, Thorpe JE (2009) Clinical review 2: the “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 94(2):410–415
Chiarugi P et al (2003) Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161:933–944
Chmurzyńska A (2006) The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 47(1):39–48
Cianflone K, Maslowska M (1995) Differentiation-induced production of ASP in human adipocytes. Eur J Clin Invest 25(11):817–825
Cianflone K et al (2004) Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res 45:124–131
Cianflone K et al (2008) Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents. Eur J Endocrinol 159(6):781–790
Cochrane CG, Unanue ER, Dixon FJ (1965) A role of polymorphonuclear leukocyte and complement in nephrotoxic nephritis. J Exp Med 122:99–116
Cocks T, Moffatt J (2000) Protease-activated receptors: sentries for inflammation. Trends Pharmacol Sci 21:103–108
Coelho AM, Ossovskaya V, Bunnett NW (2003) Proteinase-activated receptor-2: physiological and pathophysiological roles. Curr Med Chem Cardiovasc Hematol Agents 1:61–72
Cohen P et al (2002) Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:240–243
Collard CD et al (1999) Complement activation following oxidative stress. Mol Immunol 36:941–948
Cottrell G (2002) Protease activated receptors: the role of cell surface proteolysis in signaling. Essays Biochem 38:169–183
Curran CS, Bertics PJ (2011) Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B. Int Immunol 23(12):713–728
D’Souza D, Al-Sajeea D, Hawke TJ (2013) Diabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells. Front Physiol 4:Article 379, 7 pgs
de Jong AJ et al (2014) Fatty acids, lipid mediators, and T-cell function. Front Immunol 5:483
Deng T et al (2013) Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 17:411–422
Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47–95
Dugani CD (2005) Glucose transporter 4: cycling, compartments and controversies (review). EMBO Rep 6(12):1137–1142
Espinoza-Jiménez A, Peón AN, Terrazas LI (2012) Alternatively activated macrophages in types 1 and 2 diabetes. Mediators Inflamm 2012:815953
Faraj M et al (2008) Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men. Diabetes Metab 34(4 Pt 1):334–342
Feener EP, Zhou Q, Fickweiler W (2013) Role of plasma kallikrein in diabetes and metabolism (review). Thromb Haemost 110(3):434–441
Forbes JM, Copper MS (2013) Mechanisms of diabetic complications. Physiol Rev 93:137–188
Garlick RL, Bunn HF, Spiro RG (1988) Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources. Effect of diabetes and age. Diabetes 37(8):1144–1150
Goh SY, Cooper ME et al (2008) Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93(4):1143–1152
Goldfine AB et al (2011) Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion. Clin Chem 57(2):326–337
Gordon P (2003) The clinical uses of leptin. Curr Opin Pharmacol 3:655–659
Grisham MB (2004) Reactive oxygen species in immune responses. Free Radic Biol Med 36:1479–1480
Gumbs AA et al (2005) Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of caloric restriction and weight loss. Obes Surg 15:462–473
Gutterman DD, Miura H, Liu Y (2005) Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol 25:671–678
Halperin J et al (2000) Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A 97(10):5450–5455
Horakova DV et al (2011) Adipocyte fatty acid binding protein and C-reactive protein levels as indicators of insulin resistance development. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155(4):355–359
Hotta O, Yusa N, Ooyama M, Unno K, Furuta T, Taguma Y (1999) Detection of urinary macrophages expressing the CD16 molecule: a novel marker of acute inflammatory glomerular injury. Kidney Int 55:1927–1934
Hou N et al (2008) Reactive oxygen species-mediated pancreatic β-cell death is regulated by interactions between stress activated protein kinases, p38 and c-Jun N-terminal kinase and mitogen-activated protein kinase phosphatases. Endocrinology 149:1654–1665
Huang F, Horikoshi S, Kurusu A, Shibata T, Suzuki S, Funabiki K et al (2001) Urinary levels of interleukin-8 (IL-8) and disease activity in patients with IgA nephropathy. J Clin Lab Anal 15:30–34
Jenkins AJ et al. DCCT/EDIC Research Group (2008) Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. Diabetes Complications 22(3):153–163
Johnson R et al (1988) The human neutrophils serine proteinases, elastase and cathespin G can mediate glomerular injury in vivo. J Exp Med 168:1169–1174
Johnson AR, Milner JJ, Makowski L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249(1):218–238
Kadowaki T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26(3):439–451
Kam CM, Hudig D, Powers JC (2000) Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta 1477:307–323
Kanauchi M, Nishioka H, Hashimoto T (2002) Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 91:327–329
Kaneko H et al (2011) Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodeling. Cardiovasc Res 91:546–555
Kaplan A, Silverberg M, Dunn J, Ghebrehiwet B (1982) Interaction of the clotting, kinin forming, complement, and fibrinolytic pathways in inflammation. Ann N Y Acad Sci 389:25–38
Kato H (2002) Regulation of functions of vascular wall cells by tissue factor pathway inhibitor basic and clinical aspects. Arterioscler Thromb Vasc Biol 22:539–548
Knight JA (1997) Reactive oxygen species and the neurodegenerative disorders. Ann Clin Lab Sci 27:11–25
Kondo T et al (2013) Natural killer T cells in adipose tissue are activated in lean mice. Exp Anim 62(4):319–328
Kong P et al (2013) Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation. Am J Physiol Endocrinol Metab 305(3):E439–E450
Kono H, Kimura Y, Latz E (2014) Inflammasome activation in response to dead cells and their metabolites. Curr Opin Immunol 30:91–98
Kubota N et al (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277(29):25863–25866
Lee HC, Wie YH (2007) Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med 232:592–606
Lim SO et al (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135(6):2128–2140
Ma K et al (2002) Increased β-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 277(38):34658–34661
Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25:29–38
Mandard S et al (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281(2):934–944
Mania-Pramanik J et al (2004) Elastase: a predictive marker of inflammation and/or infection. J Clin Lab Anal 18:153–158
Masoodi M et al (2015) Lipid signaling in adipose tissue: connecting inflammation & metabolism. Biochim Biophys Acta 1851:503–518
McNelis JC, Olefsky JM (2014) Macrophages, immunity, and metabolic disease. Immunity 41(1):36–48
Meada N et al (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8(7):731–737
Miike S, McWilliam A, Kita H (2001) Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. J Immunol 167:6615
Minokoshi Y et al (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339–343
Nakatani K, Takeshita S (1999) Vascular endothelial cell injury by activated neutrophil and treatment for the injury. Surg Trauma Immunol Response 8:112–114
Nakatani K et al (2001) Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol 69:241–247
Nathan DM et al (2014) The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37(1):9–16
Nawrocki AR et al (2006) Mice Lacking Adiponectin show decreased hepatic insulin sensitivity and reduced pesponsiveness to peroxisome proliferator-activated receptor agonists. J Biol Chem 281(5):2654–2660
Neeper M (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267(21):14998–15004
Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9(7):484–496
Nizet V, Johnson RS (2009) Inter-dependence of hypoxic and innate immune responses. Nat Rev Immunol 9:609–617
Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219–246
Osuka K et al (2012) Adiponectin activates endothelial nitric oxide synthase through AMPK signaling after subarachnoid hemorrhage. Neurosci Lett 514(1):2–5
Ouchi N et al (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102:1296–1301
Pacurari M et al (2014) The Renin-angiotensin-aldosterone system in vascular inflammation and remodeling international (review). J Inflamm 2014:Article ID 689360, 13 pgs
Parrinello CM, Selvin E (2014) Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep 14(11):548
Patel PS, Buras ED, Balasubramanyam A (2013) The role of the immune system in obesity and insulin resistance. J Obes 2013:Article ID 616193, 9 pgs
Peake PW et al (2005) Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes. Int J Obes (Lond) 29(4):429–435
Pendyala S et al (2009) Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins (forum review article). Antioxid Redox Signal 11(4):841–860
Phieler J, Garcia-Martin R, Lambris JD, Chavakis T (2013) The role of the complement system in metabolic organs and metabolic diseases. Semin Immunol 25(1):47–53
Piconi L (2003) Oxidative stress in diabetes. Clin Chem Lab Med 41(9):1144–1149
Pitocco D (2013) Oxidative stress in diabetes: implications for vascular and other complications. Int J Mol Sci 14:21525–21550
Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr Rev 29:351–366
Poon AK et al (2014) Comparative associations of diabetes risk factors with five measures of hyperglycemia. BMJ Open Diab Res Care 2(1):e000002
Preedy VR, Hunter RJ (eds) (2011) Adipokines, 1st edn. CRC Press LCC, New York, NY. pp 1–458. ISBN 9781578086894
Pucino V et al (2014) Regulatory T cells, leptin and angiogenesis. Chem Immunol Allergy 99:155–169
Pugia MJ, Valdes R, Jortani SA (2007) Chapter on urinary trypsin inhibitors: structure, biological relevance and measurement. In: Makowski G (ed) Advances in clinical chemistry, vol 44. Academic Press. Elsevier, New York, NY. ISBN 10: 0-12-373704-4
Rahbar S (2005) The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems. Ann N Y Acad Sci 1043:9–19
Ramasamy R, Yan SF, Schmidt AM (2011) Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 1243:88–102
Ramírez-Boo M et al (2012) Characterization of the glycated human cerebrospinal fluid proteome. J Proteomics 75(15):4766–4782
Rao X, Zhong J, Sun Q (2014) The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetes. Life Sci 116(2):59–66
Riad A (2007) The role of the renal kallikrein–kinin system in diabetic nephropathy. Curr Opin Nephrol Hypertens 16(1):22–26
Roberts AC, Porter KE (2013) Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diab Vasc Dis Res 10(6):472–482
Satoh N. Leptin to adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care. 2004;27(10):2488–2490
Seifert EL et al (2010) Electron transport chain-dependent and -independent mechanisms of mitochondrial H2O2 emission during long-chain fatty acid oxidation. J Biol Chem 285(8):5748–5758
Skolnik EY et al (1991) Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931–939
Smith MM (2012) Minson CT obesity and adipokines: effects on sympathetic overactivity. J Physiol 590(Pt 8):1787–1801
Sorisky A, Magun R, Gagnon AM (2000) Adipose cell apoptosis: death in the energy depot. Int J Obes 24(Suppl 4):S3–S7
Storz P (2005) Reactive oxygen species in tumor progression. Front Biosci 10:1881–1896
Stralfors P, Honnor RC (1989) Insulin-induced dephosphorylation of hormone-sensitive lipase. Eur J Biochem 182(2):379
Sweeney G (2002) Leptin signaling. Cell Signal 14:655–663
Throckmorton DC et al (1995) PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48:111–117
Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772–783
Trapani JA (2001) Granzymes: a family of lymphocyte granule serine proteases. Genome Biol 2:30141–30147
Travers RL et al (2015) The impact of adiposity on adipose tissue-resident lymphocyte activation in humans. Int J Obes (Lond) 39:762–769
Trayhurn P, Bohan Wang B, Wood SI (2008) Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100:227–235
Tsuriya D et al (2011) Significant correlation between visceral adiposity and high-sensitivity C-reactive protein (hs-CRP) in Japanese subjects. Intern Med 50:2767–2773
Ulven SM et al (2005) LXR is crucial in lipid metabolism prostaglandins. Leukot Essent Fatty Acids 73:59–63
Valencia JV et al (2004) Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia 47(5):844–852
Vila IK et al (2014) Immune cell toll-like receptor 4 mediates the development of obesity- and endotoxemia- associated adipose tissue fibrosis. Cell Rep 7(4):1116–1129
Wa C et al (2007) Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta 385(1–2):48–60
Wang X, Nakayama T (2010) Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010:Article ID 535918, 17 pgs
Wang Y et al (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280(18):18341–18347
Wautier JL et al (1996) Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 97(1):238–243
Weil BR et al (2011) Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol 301(3):H689–H695
Wilkinson-Berka JL et al (2013) Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy (review). Clin Sci (Lond) 124(10):597–615
Winter WE, Schatz DA (2011) Autoimmune markers in diabetes. Clin Chem 57(2):168–175
Yamauchi T et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8(11):1288–1295
Yan L (2014) Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress (review). J Diab Res 2014:137919
Yang JJ (1996) Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol 149(5):1617–1626
Zhang DX, Gutterman DD (2007) Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 292:H2023–H2031
Zhang Y et al (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432
Zhang Q et al (2008) Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes. J Proteome Res 7(5):2025–2032
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pugia, M. (2015). Impact of Inflammation and Innate Immunity Response in Obesity Mediated Diabetes. In: Pugia, M. (eds) Inflammatory Pathways in Diabetes. Progress in Inflammation Research. Springer, Cham. https://doi.org/10.1007/978-3-319-21927-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-21927-1_1
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-21926-4
Online ISBN: 978-3-319-21927-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)